MedPath

COVID-19 Nasal Swab Trial

Not Applicable
Completed
Conditions
Covid19
Registration Number
NCT04649424
Lead Sponsor
Orthopaedic Innovation Centre
Brief Summary

The purpose of this trial is to compare 2 types of nasonasopharyngeal swabs (a new design to a conventional nylon-flocked nasopharyngeal swab) for effectiveness.

Detailed Description

Compare the Precision ADM "CanSwab" nasopharyngeal swab to a conventional nylon-flocked nasopharyngeal swab on the basis of:

1. The amount of SARS-CoV2 virus (COVID-19) collected by swabs, measured in CT (thermal cycles)

2. Clinical concordance rate

3. Patient comfort during nasopharyngeal sampling procedure

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
169
Inclusion Criteria
  • 18 years and older
  • Ability to provide informed consent
  • COVID-19 positive cohort only: a previous, positive COVID-19 test in the last 5 days and patient remains symptomatic

Exclusion criteria:

  • Malformation of the base of the known skull
  • Active nosebleed before the start of the sample
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Amount of SARS-CoV2 virus (COVID-19) collectedBaseline

amount of SARS-CoV2 virus (COVID-19) collected measured in CT (thermal cycles).

Clinical concordance rateBaseline

Calculate approximate sensitivity and specificity of the CanSwab to the Flocked swab control.

Patient comfortBaseline

Patient description of comfort level between the 2 swabs experience measured by "Worse", "Identical" or "Better"

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

St. Boniface General Hospital

🇨🇦

Winnipeg, Manitoba, Canada

Health Sciences Centre

🇨🇦

Winnipeg, Manitoba, Canada

St. Boniface General Hospital
🇨🇦Winnipeg, Manitoba, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.